Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2015 | 07-2014 | 07-2013 | 07-2012 | 07-2011 | |
| Sales | 0 | 0 | 0 | 4,260 | 4,532 |
| Cost of Goods | N/A | N/A | N/A | 1,741 | 1,642 |
| Gross Profit | N/A | N/A | N/A | 2,519 | 2,890 |
| Operating Expenses | 8,777 | 8,735 | 8,228 | 13,118 | 15,367 |
| Operating Income | -8,777 | -8,735 | -8,228 | -10,599 | -12,477 |
| Interest Expense | 13 | 19 | 25 | 17 | N/A |
| Other Income | 10 | 72 | 59 | -6,807 | 1,463 |
| Pre-tax Income | -8,780 | -8,682 | -8,194 | -17,423 | -11,014 |
| Income Tax | N/A | N/A | N/A | 0 | 334 |
| Net Income Continuous | -8,780 | -8,682 | -8,194 | -17,423 | -11,348 |
| Net Income Discontinuous | 50 | 0 | 6,649 | N/A | N/A |
| Net Income | $-8,730 | $-8,682 | $-1,545 | $-17,423 | $-11,348 |
| EPS Basic Total Ops | -0.55 | -0.60 | -0.10 | -1.30 | -0.85 |
| EPS Basic Continuous Ops | -0.55 | -0.60 | -0.60 | -1.30 | -0.85 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.55 | -0.60 | -0.10 | -1.30 | -0.85 |
| EPS Diluted Continuous Ops | -0.55 | -0.60 | -0.60 | -1.30 | -0.85 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 |
| EBITDA(a) | $-8,634 | $-8,431 | $-7,773 | $-16,707 | $-12,073 |